Milk-alkali syndrome classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Milk-alkali syndrome}}
==Overview==
There is no established system for the classification of [disease name].


OR
{{CMG}} {{AE}} {{SHA}}


[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
== Overview ==
 
Milk-alkali syndrome may be classified as the following: acute (toxemic form), subacute (Cope's syndrome), and chronic (Burnett's syndrome).
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==


There is no established system for the classification of [disease name].
In all types of milk-alkali syndrome there are increases in [[calcium]], [[Blood urea nitrogen|BUN]], [[creatinine]], and there are normal or increased [[phosphorus]]. Milk-alkali syndrome may be classified as the following:<ref name="pmid5851468">{{cite journal| author=McMillan DE, Freeman RB| title=The milk alkali syndrome: a study of the acute disorder with comments on the development of the chronic condition. | journal=Medicine (Baltimore) | year= 1965 | volume= 44 | issue= 6 | pages= 485-501 | pmid=5851468 | doi=10.1097/00005792-196511000-00002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5851468  }} </ref> 
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
*[Group1]
*[Group2]
*[Group3]
*[Group4]
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on:
*[Classification method 1]
*[Classification method 2]
*[Classification method 3]
 
[Disease name] may be classified into several subtypes based on:  
*[Classification method 1]
*[Classification method 2]
*[Classification method 3]
 
OR


Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
==== Acute or Toxemic Form ====
*The acute or toxemic form occurs about one week after treatment with milk and [[alkali]].
*They have symptoms of acute hypercalcemia such as:
**[[Headache]], [[dizziness]]
**[[Lethargy]]
**[[Nausea and vomiting|Nausea, vomiting]]
**[[Anorexia]]  
**[[Muscle weakness|Weakness]]
**Mental changes such as [[psychosis]]


OR
* Acute [[renal insufficiency]]


'''If the staging system involves specific and characteristic findings and features:'''
*[[Metabolic alkalosis]]
*Withdrawal of milk and [[alkali]] resolves the symptoms and [[renal function]] to normal, rapidly.


According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
===== Subacute or Cope's Syndrome =====


OR
*Usually seen in patients that have taken milk and [[alkali]] intermittently for years.
*Patients have symptoms of both acute and chronic hypercalcemia and respond to medication withdrawal with gradual improvement. [[Renal function]] improves gradually but significantly.


The staging of [malignancy name] is based on the [staging system].
===== Chronic or Burnett's Syndrome =====


OR
*Patients have a long history of high milk and [[alkali]] consumption.
*They have symptoms of chronic [[hypercalcemia]] such as:
**Occasional [[Nausea and vomiting|nausea, vomiting]], [[anorexia]] and mental changes  
**[[Asthenia]]  
**[[Polyuria]]
**[[Polydipsia]]
**[[Pruritus]]
**[[Myalgia]]
*[[Metastatic calcification|Metastatic calcifications]] (band keratopathy and [[nephrocalcinosis]])
*[[Laboratory]] abnormalities are similar to those in the acute syndrome, but the response to the withdrawal of milk and [[alkali]] is quite different.
*[[Myalgia]] and [[Itch|pruritus]] improves slowly as [[calcium]] level slowly normalizes.
*[[Calcium]] levels resolve to a normal level, gradually and some abnormal [[calcification]] decrease.
*There is usually minimal or no improvement in [[renal function]], as many patients continue to have [[chronic renal failure]].<ref name="pmid18126919">{{cite journal |vauthors=BURNETT CH, COMMONS RR |title=Hypercalcemia without hypercalcuria or hypophosphatemia, calcinosis and renal insufficiency; a syndrome following prolonged intake of milk and alkali |journal=N. Engl. J. Med. |volume=240 |issue=20 |pages=787–94 |date=May 1949 |pmid=18126919 |doi=10.1056/NEJM194905192402001 |url=}}</ref><ref name="pmid16268810">{{cite journal |vauthors=Picolos MK, Lavis VR, Orlander PR |title=Milk-alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients |journal=Clin. Endocrinol. (Oxf) |volume=63 |issue=5 |pages=566–76 |date=November 2005 |pmid=16268810 |doi=10.1111/j.1365-2265.2005.02383.x |url=}}</ref>


There is no established system for the staging of [malignancy name].==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WH}}

Latest revision as of 13:02, 16 July 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]

Overview

Milk-alkali syndrome may be classified as the following: acute (toxemic form), subacute (Cope's syndrome), and chronic (Burnett's syndrome).

Classification

In all types of milk-alkali syndrome there are increases in calcium, BUN, creatinine, and there are normal or increased phosphorus. Milk-alkali syndrome may be classified as the following:[1]

Acute or Toxemic Form

Subacute or Cope's Syndrome
  • Usually seen in patients that have taken milk and alkali intermittently for years.
  • Patients have symptoms of both acute and chronic hypercalcemia and respond to medication withdrawal with gradual improvement. Renal function improves gradually but significantly.
Chronic or Burnett's Syndrome

References

  1. ↑ McMillan DE, Freeman RB (1965). "The milk alkali syndrome: a study of the acute disorder with comments on the development of the chronic condition". Medicine (Baltimore). 44 (6): 485–501. doi:10.1097/00005792-196511000-00002. PMID 5851468.
  2. ↑ BURNETT CH, COMMONS RR (May 1949). "Hypercalcemia without hypercalcuria or hypophosphatemia, calcinosis and renal insufficiency; a syndrome following prolonged intake of milk and alkali". N. Engl. J. Med. 240 (20): 787–94. doi:10.1056/NEJM194905192402001. PMID 18126919.
  3. ↑ Picolos MK, Lavis VR, Orlander PR (November 2005). "Milk-alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients". Clin. Endocrinol. (Oxf). 63 (5): 566–76. doi:10.1111/j.1365-2265.2005.02383.x. PMID 16268810.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Milk-alkali_syndrome_classification&oldid=1627812"